The biosimilars distribution companies in nan focus on providing biologic medications that are similar, but not identical, to already approved and marketed products. This industry is characterized by established pharma companies and innovative startups alike, all aiming to create accessible healthcare options through the development of biosimilars. As healthcare costs rise, the shift towards biosimilars is seen as a strategic response to enhance patient access to effective treatment without the high price tag of original biologics. Moreover, increasing regulatory support and demand for efficient health solutions position this sector for continued growth and innovation in the coming years.


The listed companies represent a varied spectrum of the biosimilars distribution industry. Spanning multiple continents from North America to Europe and Asia, these firms vary in size from small teams to thousands of employees. Many have deep roots, founded as far back as the late 20th century. Their specializations include the comprehensive development and marketing of biosimilars and generics primarily in oncology, immunology, and other therapeutic areas, reflecting an enduring commitment to healthcare accessibility.


Continue reading to explore the top biosimilars distribution companies.


Top 26 Biosimilars Distribution Companies


1. Sandoz Canada

  • Website: sandoz.ca
  • Ownership type: Corporate
  • Headquarters: Boucherville, Quebec, Canada
  • Employee distribution: Canada 100%
  • Latest funding: May 2018
  • Founded year: 1980
  • Headcount: 201-500
  • LinkedIn: sandozcanada

Sandoz Canada, established in 1980 and located in Boucherville, Quebec, is a corporate entity that specializes in the development and distribution of generic and biosimilar medicines. With a workforce of approximately 234 employees, the company is dedicated to ensuring that healthcare professionals and patients have access to affordable medications. Sandoz Canada emphasizes innovation and quality in its product offerings, which include a range of biosimilars aimed at providing effective treatment options at lower costs. Their commitment to corporate responsibility and patient support programs further highlights their role in the healthcare sector. Sandoz is part of a larger global network, which enhances its capabilities in the biosimilars market, allowing it to contribute significantly to the accessibility of essential medications in Canada.


2. Pharmalink Drug Store

  • Website: pharmalink.ae
  • Ownership type: Private
  • Headquarters: Abu Dhabi, Abu Dhabi, United Arab Emirates (UAE)
  • Employee distribution: United Arab Emirates 98%, Other 2%
  • Founded year: 1994
  • Headcount: 501-1000
  • LinkedIn: pharmalink-drug-store

Pharmalink Drug Store, established in 1994, is a private pharmaceutical company based in Abu Dhabi, UAE. With a workforce of around 821 employees, the company has built a reputation for providing healthcare solutions that include the manufacturing and distribution of medications. Pharmalink aims to enhance patient access to quality healthcare across the Gulf Cooperation Council (GCC) region. Their portfolio features a range of products, including biosimilars, prescription brands, and branded generics, catering to various therapeutic areas such as oncology, respiratory care, and pain management. The company operates a chain of pharmacies under the brand Medicina, which has expanded to over 130 locations throughout the UAE. Pharmalink emphasizes innovative marketing strategies and robust regulatory affairs to ensure compliance and quality in their offerings. They have established a strong logistical framework to support their distribution efforts, ensuring that medications reach healthcare providers and patients efficiently.


3. Samsung Bioepis

  • Website: samsungbioepis.com
  • Ownership type: Corporate
  • Headquarters: Yeonsu-Gu, Incheon, South Korea
  • Employee distribution: South Korea 91%, Netherlands 3%, Other 6%
  • Latest funding: January 2022
  • Founded year: 2012
  • Headcount: 501-1000
  • LinkedIn: samsungbioepis

Samsung Bioepis, founded in 2012 and based in Yeonsu-Gu, Incheon, South Korea, is a biopharmaceutical company dedicated to the development and commercialization of biosimilar medicines. The company aims to improve patient access to high-quality biologic therapies, particularly in the fields of immunology and oncology. With a workforce of approximately 1,584 employees, Samsung Bioepis has built a significant portfolio of biosimilars, including products that have received approvals from regulatory bodies such as the FDA and the European Commission. Their innovative approach to drug development and commitment to quality assurance have allowed them to secure a strong foothold in the biosimilars market. The company collaborates with partners like Biogen, Organon, and Sandoz to ensure the effective distribution of their products globally. Samsung Bioepis continues to expand its pipeline, exploring new therapeutic areas such as ophthalmology and gastroenterology, which reflects their ongoing commitment to addressing unmet medical needs.


4. Les Laboratoires FRATER-RAZES

  • Website: frater-razes.com
  • Ownership type: Private
  • Headquarters: Algiers [El Djazaïr], Algiers, Algeria
  • Employee distribution: Algeria 99%
  • Founded year: 1992
  • Headcount: 1001-5000
  • LinkedIn: laboratoires-frater-razes

Les Laboratoires FRATER-RAZES, founded in 1992 by Dr. Abdelhamid Cherfaoui, is a prominent pharmaceutical company based in Algiers, Algeria. The company specializes in the production and distribution of a wide range of medications, including generics and biosimilars. With a workforce of over 500 employees, they have built a robust industrial complex equipped with advanced technologies that meet international standards. FRATER-RAZES is dedicated to ensuring access to high-quality pharmaceutical products for healthcare professionals, hospitals, and pharmacies. Their commitment to quality is reflected in their rigorous adherence to good manufacturing practices and their ISO 9001:2015 certification. The company is also involved in various therapeutic areas, including oncology, infectious diseases, and cardiology, and actively participates in initiatives aimed at improving public health in Algeria. Their focus on biosimilars positions them well within the pharmaceutical industry, as they contribute to making essential medications more accessible.


5. Kern Pharma

  • Website: kernpharma.com
  • Ownership type: Private
  • Headquarters: Terrassa, Catalonia, Spain
  • Employee distribution: Spain 96%, Other 4%
  • Founded year: 1999
  • Headcount: 501-1000
  • LinkedIn: kern-pharma

Kern Pharma, founded in 1999 and based in Terrassa, Catalonia, Spain, is a private pharmaceutical company that specializes in the development, manufacturing, and marketing of generic drugs, biosimilars, and health products. With a workforce of approximately 873 employees, the company serves healthcare professionals, pharmacies, and patients, focusing on providing affordable medication solutions. Kern Pharma operates in over 60 countries, including international subsidiaries in Portugal and the United States. Their biosimilars division collaborates with Celltrion Healthcare to offer several monoclonal antibodies approved by the European Medicines Agency. This strategic partnership allows Kern Pharma to enhance its product offerings and reach within the biosimilars market. The company is also involved in producing active pharmaceutical ingredients and has a robust portfolio that covers a significant portion of prescription needs, showcasing their commitment to quality and innovation in the pharmaceutical industry.


6. Polpharma Biologics

  • Website: polpharmabiologics.com
  • Ownership type: Private
  • Headquarters: Brodnica Dolna, Pomeranian Voivodeship, Poland
  • Employee distribution: Poland 90%, Netherlands 8%, Other 1%
  • Founded year: 1935
  • Headcount: 1001-5000
  • LinkedIn: polpharmabiologics

Polpharma Biologics is a biotechnology firm based in Brodnica Dolna, Poland, with a history dating back to 1935. The company is dedicated to the development and manufacturing of biosimilars, which are biologic medical products highly similar to already approved reference products. Polpharma Biologics operates state-of-the-art facilities in Poland and the Netherlands, focusing on innovation and quality in their production processes. They have a robust pipeline of biosimilars targeting various therapeutic areas, and they actively collaborate with some of the largest biotechnology and pharmaceutical companies to ensure their products reach a wide patient population. Their commitment to improving patient access to essential therapies is evident in their operational strategies and partnerships.


7. Adalvo

  • Website: adalvo.com
  • Ownership type: Private Equity
  • Headquarters: San Ġwann, Malta
  • Employee distribution: India 31%, Bulgaria 17%, Malta 17%, Other 35%
  • Latest funding: April 2024
  • Founded year: 2020
  • Headcount: 201-500
  • LinkedIn: adalvopr

Adalvo, founded in 2020 and based in San Ġwann, Malta, is a pharmaceutical company that focuses on the development and distribution of generic pharmaceuticals and biosimilars. With a workforce of around 200 employees, the company operates a comprehensive portfolio that includes specialty generics and value-added medicines. Adalvo emphasizes B2B partnerships, aiming to provide high-quality products to healthcare providers and pharmaceutical companies. Their commitment to improving patient lives is evident in their strategic initiatives and product offerings. Adalvo has received recognition in the industry, winning awards such as Business Development of the Year and Value Added Medicine of the Year at the Global Generics & Biosimilars Bulletin Awards. Their ongoing projects, including the development of a global dossier for Fidaxomicin, further demonstrate their active role in the biosimilars market.


8. iQone Healthcare Switzerland


iQone Healthcare Switzerland, founded in 2014, is a pharmaceutical company based in Versoix, Geneva. The firm specializes in biosimilars and therapeutic advances, aiming to improve patient care by ensuring that healthcare professionals have access to innovative medicines. With a team of 22 employees, iQone operates with a focus on oncology, immunology, and other therapeutic areas, including rheumatology and gastroenterology. The company prides itself on its agile approach to distribution, allowing for quick onboarding of new products and efficient delivery services across Switzerland. iQone has built strong partnerships with global manufacturers, notably serving as the main distributor for Celltrion Healthcare in Switzerland. Their commitment to social responsibility and cost-effective healthcare solutions further underscores their role in the pharmaceutical industry, particularly in the biosimilars segment.


9. Accord Healthcare Brazil

  • Website: accordfarma.com.br
  • Ownership type: Private
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Employee distribution: Brazil 100%
  • Founded year: 1990
  • Headcount: 51-200
  • LinkedIn: accord-farma

Accord Healthcare Brazil, also known as Accord Farma, is a bio-pharmaceutical company based in São Paulo, Brazil. Founded in 1990, the company has established itself as a key player in the development and manufacturing of biosimilars and generics. Accord operates in over 85 countries, providing essential medications primarily in oncology, hematology, and critical therapies. The company is a part of the Intas Pharmaceuticals group, which enhances its capabilities and market reach. Accord Healthcare Brazil is dedicated to improving patient access to high-quality medications, having launched over 40 products in Brazil across various therapeutic areas, including nephrology and infectious diseases. Their commitment to innovation and quality is evident in their production processes, which adhere to the standards set by major global regulatory agencies such as FDA and ANVISA. Additionally, Accord employs advanced technologies like PharmaShield® to ensure the safety and efficacy of their products, further solidifying their position in the bio-pharmaceutical industry.


10. Usv Private Limited

  • Website: usvindia.com
  • Ownership type: Private
  • Headquarters: Mumbai, Maharashtra, India
  • Employee distribution: India 99%
  • Founded year: 1961
  • Headcount: 5001-10000
  • LinkedIn: usv-limited

Usv Private Limited, founded in 1961 and based in Mumbai, Maharashtra, is a pharmaceutical and biotechnology company that specializes in a wide array of healthcare products. The company produces Active Pharmaceutical Ingredients (APIs), biosimilars, injectables, and more. With a workforce of over 5,000 employees, Usv operates primarily in India, but also extends its reach to various international markets. The company is particularly noted for its commitment to biosimilars, investing in extensive research and development to ensure high-quality products. Their biosimilar research includes advanced techniques such as molecular biology and bioassays, which are crucial for developing effective biosimilar therapies. Usv's strategic initiatives, including recent expansions into markets like Germany, further demonstrate their ambition and capability in the pharmaceutical sector.


11. Qilu Pharma Spain

  • Website: qilu-pharma.es
  • Ownership type: Private
  • Headquarters: Madrid, Madrid, Spain
  • Employee distribution: Spain 89%, China 11%
  • Founded year: 1958
  • Headcount: 10001+
  • LinkedIn: qilu-pharma-spain

Qilu Pharma Spain, based in Madrid, is the European subsidiary of Qilu Pharmaceutical, a prominent player in the pharmaceutical industry since its founding in 1958. The company focuses on the research, development, manufacturing, and marketing of generic and biosimilar medicines. With a commitment to high-quality production, Qilu Pharma Spain utilizes advanced technologies and adheres to strict quality standards, ensuring that their products meet the needs of healthcare professionals and patients alike. They have a significant presence in the biosimilars market, having launched several products in China and planning to expand their offerings in the next few years. Their portfolio includes over 200 products, including active pharmaceutical ingredients (APIs) and finished dosage forms, catering to various therapeutic areas such as oncology, infectious diseases, and cardiovascular health. Qilu Pharma Spain operates with a strong focus on improving patient outcomes and making treatments accessible, reflecting their mission to enhance the quality of life for those with serious health conditions.


12. Cordavis

  • Website: cordavis.com
  • Ownership type: Private
  • Headquarters: Dublin, Dublin, Ireland
  • Employee distribution: Ireland 93%, United Kingdom (UK) 7%
  • Founded year: 2023
  • Headcount: 11-50
  • LinkedIn: cordavis

Cordavis is a private pharmaceutical company based in Dublin, Ireland, founded in 2023. As a subsidiary of CVS Health, Cordavis is dedicated to the development and distribution of FDA-approved biosimilars. The company collaborates with manufacturers to ensure that these biologic medications are not only high-quality but also affordable for patients in the U.S. market. With a focus on enhancing access to essential medications, Cordavis aims to support a competitive biosimilar market that drives cost savings for consumers. Their logistics management system is designed to improve delivery predictability, ensuring that patients receive their medications reliably. The leadership team at Cordavis brings extensive experience from various sectors of healthcare, which positions the company to effectively navigate the complexities of the pharmaceutical industry.


13. Spirig HealthCare AG

  • Website: spirig-healthcare.ch
  • Ownership type: Family Owned
  • Headquarters: Egerkingen, Solothurn, Switzerland
  • Employee distribution: Switzerland 100%
  • Founded year: 2011
  • Headcount: 51-200
  • LinkedIn: spirig-healthcare-ag

Spirig HealthCare AG, founded in 2011 and based in Egerkingen, Switzerland, is a family-owned pharmaceutical company that specializes in the development and distribution of a wide array of healthcare products. Their portfolio includes generics, biosimilars, and consumer healthcare items, catering to healthcare professionals, pharmacies, and consumers alike. With a workforce of approximately 81 employees, Spirig HealthCare emphasizes quality and innovation in its operations. The company is particularly noted for its commitment to biosimilars, which are biotechnologically produced drugs that provide therapeutic alternatives to original biopharmaceuticals. Spirig HealthCare's involvement in this sector reflects its dedication to enhancing patient care while also addressing cost-effectiveness in healthcare. The company has been part of the Swiss healthcare market for over 75 years, contributing significantly to the availability of pharmaceutical products. Since 2012, it has been a subsidiary of STADA Arzneimittel AG, further solidifying its position in the industry.


14. Shilpa Biologicals Private Limited


Shilpa Biologicals Private Limited, founded in 2007 and based in Dharwad, Karnataka, India, is a biopharmaceutical company dedicated to the development of affordable biosimilars. With a workforce of approximately 282 employees, the company emphasizes innovative solutions to enhance patient access to essential medications. Shilpa Biologicals is actively engaged in the research and development of a range of biosimilars, including those targeting conditions like rheumatoid arthritis and various cancers. Their product pipeline showcases several biosimilars at different stages of clinical development, reflecting their commitment to expanding access to biologic therapies. In addition to biosimilars, Shilpa Biologicals offers contract development and manufacturing services, catering to global pharmaceutical and healthcare clients. This dual focus on biosimilars and CDMO services positions the company as a significant player in the biopharmaceutical sector.


15. Prime Pharmaceuticals


Prime Pharmaceuticals, founded in 1968 and based in Mumbai, Maharashtra, India, is a private pharmaceutical manufacturer that specializes in the development and production of finished dosage formulations, biosimilars, and DC granules. The company serves healthcare professionals and organizations by providing high-quality pharmaceutical products aimed at enhancing patient care. With a robust focus on research and development, Prime Pharmaceuticals operates in over 50 countries, ensuring a significant global footprint in the healthcare market. They have invested in a biosimilars facility in Chennai, which adheres to EMA guidelines and is equipped for the production of vials, cartridges, and prefilled syringes. Their commitment to quality and innovation is evident in their ongoing clinical trials and product pipeline, which includes several biosimilar products slated for international registration. Prime Pharmaceuticals is dedicated to improving healthcare outcomes and has established a reputation for customer-centric service and regulatory compliance.


16. AryoGen Pharmed

  • Website: aryogen.com
  • Ownership type: Private
  • Headquarters: Iran
  • Employee distribution: Iran 99%
  • Founded year: 2009
  • Headcount: 501-1000
  • LinkedIn: aryogen-biopharma

AryoGen Pharmed is a private biopharmaceutical manufacturer based in Iran, founded in 2009. The company specializes in the production of biosimilars and biogenerics, aiming to enhance the quality of life for patients suffering from serious medical conditions, including various cancers and blood disorders. AryoGen is dedicated to providing affordable access to essential medications, collaborating with healthcare professionals to ensure effective treatment options are available. With a workforce of approximately 500 to 1000 employees, AryoGen has made significant strides in the biopharmaceutical industry, exporting products to 21 countries and producing a range of life-saving drugs. Their commitment to quality and innovation is evident in their extensive product line, which includes biosimilars like Trastuzumab and Rituximab, among others. AryoGen's focus on research and development positions them as a proactive entity in the healthcare sector, striving to meet the needs of patients and healthcare providers alike.


17. Biogaran

  • Website: biogaran.fr
  • Ownership type: Private
  • Headquarters: Colombes, Île-De-France, France
  • Employee distribution: France 92%, Other 8%
  • Founded year: 1996
  • Headcount: 201-500
  • LinkedIn: biogaran

Biogaran, founded in 1996 and based in Colombes, Île-De-France, is a private pharmaceutical company dedicated to the production of generic and biosimilar medications. With a workforce of approximately 551 employees, the company primarily serves the French market, where it holds a significant share in the distribution of affordable healthcare solutions. Biogaran's portfolio includes a wide array of health products, dietary supplements, and over-the-counter medications. Since 2015, the company has expanded its focus to include biosimilars, aiming to enhance patient access to innovative treatments for serious health conditions. Biogaran is committed to maintaining high standards of quality and effectiveness in its products, ensuring that patients receive reliable alternatives to costly biologic therapies. The company also engages in various initiatives to support healthcare professionals and patients alike, reinforcing its role in the healthcare ecosystem.


18. Apobiologix

  • Website: apobiologix.com
  • Ownership type: Private
  • Headquarters: Toronto, Ontario, Canada
  • Employee distribution: Canada 78%, United States (USA) 22%
  • Founded year: 2007
  • Headcount: 51-200
  • LinkedIn: apobiligix

Apobiologix, based in Toronto, Ontario, is a private pharmaceutical company founded in 2007. It specializes in the development and commercialization of biosimilars, with a particular emphasis on oncology. As a division of Apotex Inc., Apobiologix aims to transform access to affordable biologic medicines in Canada. The company is dedicated to enhancing patient care through comprehensive support programs and educational resources tailored for healthcare providers. Their initiatives include the Apobiologix Partnership Program, which collaborates with healthcare professionals to optimize patient care and ensure sustainability in the healthcare system. Apobiologix is recognized for its pioneering efforts in oncology biosimilars, contributing to the education and awareness of biosimilars among key stakeholders. With a workforce of around 51-200 employees, the company operates primarily in Canada, with a smaller presence in the United States.


19. Hetero México

  • Website: heterodrugs.mx
  • Ownership type: Private
  • Headquarters: Mexico City, Mexico City, Mexico
  • Employee distribution: Mexico 100%
  • Founded year: 2011
  • Headcount: 51-200
  • LinkedIn: hetero-mexico

Hetero México, established in 2011, operates out of Mexico City and is a private company with a workforce of approximately 51-200 employees. The firm specializes in the manufacturing of generic drugs, active pharmaceutical ingredients, and biosimilars. Hetero México is part of Hetero Group, a significant player in the pharmaceutical industry, particularly known for its production of anti-retrovirals. The company aims to improve access to essential medicines by offering affordable options across various therapeutic areas, including oncology and virology. Hetero México has been actively expanding its portfolio, launching its own branded molecules through its subsidiary Amarox Pharma. The company is committed to quality and has established a reputation for reliability in the pharmaceutical market.


20. EG Italia Gruppo STADA

  • Website: egstada.it
  • Ownership type: Private
  • Headquarters: Milan, Lombardy, Italy
  • Employee distribution: Italy 100%
  • Founded year: 1998
  • Headcount: 201-500
  • LinkedIn: eg-italia-gruppo-stada

EG Italia Gruppo STADA, based in Milan, Lombardy, has been a significant player in the pharmaceutical industry since its establishment in 1998. The company specializes in the production and distribution of generic drugs, consumer healthcare products, and notably, biosimilars. With a workforce of approximately 154 employees, EG STADA operates entirely within Italy, ensuring a focused approach to the local market. As part of the STADA Group, a multinational pharmaceutical entity founded in 1895, EG STADA benefits from a rich heritage and extensive resources. Their commitment to health and wellness is evident in their mission to provide effective and affordable medication options, positioning them as a trusted partner for both patients and healthcare professionals. The company’s involvement in biosimilars reflects a strategic initiative to address the growing demand for biologic therapies, contributing to improved patient outcomes and healthcare accessibility.


21. JHL Biotech

  • Website: edenbiologics.com
  • Ownership type: Corporate
  • Headquarters: Zhubei, Hsinchu, Taiwan
  • Latest funding: $50.0M, May 2022
  • Founded year: 2012
  • Headcount: 51-200
  • LinkedIn: jhl-biotech

Eden Biologics, formerly known as JHL Biotech, is a biopharmaceutical company based in Zhubei, Hsinchu, Taiwan. Founded in 2012, the company specializes in the development of biosimilars and offers contract development and manufacturing services to pharmaceutical and biotechnology firms. Eden Biologics aims to simplify the process of bringing biosimilar products to market, ensuring that patient needs are met with high-quality, affordable biotechnology medicines. The company has a significant pipeline of proprietary biosimilars and has successfully navigated regulatory approvals in multiple countries. In 2022, Eden Biologics secured $50 million in funding, which underscores its potential for growth and innovation in the biosimilars sector. Their focus on innovative manufacturing processes and commitment to quality positions them as a noteworthy player in the biopharmaceutical industry.


22. ApoPharma Inc.

  • Website: apopharma.com
  • Ownership type: Private
  • Headquarters: Toronto, Ontario, Canada
  • Founded year: 2004
  • Headcount: 51-200
  • LinkedIn: apopharma-inc

ApoPharma Inc., based in Toronto, Ontario, Canada, is a private pharmaceutical company founded in 2004. The company is part of Apotex, which is recognized as the largest Canadian-based pharmaceutical entity. ApoPharma specializes in the manufacturing and distribution of generic, biosimilar, and innovative branded medications. Their mission is to enhance access to affordable healthcare products for patients and healthcare professionals. With a workforce of approximately 60 employees, ApoPharma has established itself as a significant player in the pharmaceutical industry, particularly in the biosimilars segment. They are committed to innovation and expanding their product offerings, which includes a range of biosimilars aimed at providing cost-effective alternatives to expensive biologic therapies.


23. JAMP Pharma Group

  • Website: jamppharma.ca
  • Ownership type: Private
  • Headquarters: Montreal, Quebec, Canada
  • Employee distribution: Canada 62%, India 37%
  • Founded year: 1988
  • Headcount: 201-500
  • LinkedIn: jamp-pharma-corporation

JAMP Pharma Group, founded in 1988 and based in Montreal, Quebec, is a private pharmaceutical company that specializes in a wide array of medications and health solutions. With a workforce of approximately 608 employees, the company operates primarily in Canada, serving healthcare professionals, pharmacies, and consumers. JAMP Pharma offers a mix of generic and branded drugs, natural health products, and beauty items. A notable aspect of their operations is the BioJAMP division, which is dedicated to biosimilars, showcasing their commitment to this growing market. The company has made significant strides in the pharmaceutical industry, including the launch of several biosimilars, which positions them as a relevant player in this sector. JAMP Pharma is also recognized for its strong supply chain and extensive sales force, which supports its mission to improve access to affordable medicines for Canadians.


24. EG LABO - Groupe STADA

  • Website: eglabo.fr
  • Ownership type: Private
  • Headquarters: Issy-Les-Moulineaux, Île-De-France, France
  • Employee distribution: France 96%, Italy 4%
  • Founded year: 1996
  • Headcount: 51-200
  • LinkedIn: eg-labo

EG LABO - Groupe STADA, founded in 1996 and based in Issy-Les-Moulineaux, France, is a private pharmaceutical company specializing in the development and distribution of generic medications and health products. With a workforce of approximately 159 employees, the company serves healthcare professionals, including pharmacists and hospitals, by offering a comprehensive range of affordable medications. Their product portfolio includes over 820 specialties, covering various therapeutic classes. Notably, EG LABO has ventured into the biosimilars market, having commercialized two biosimilars, which reflects their commitment to expanding their offerings in this area. The company operates primarily in France, with a small presence in Italy, and is dedicated to ensuring that patients have access to essential medications. Their affiliation with the STADA Group further strengthens their position in the pharmaceutical industry, allowing them to leverage additional resources and expertise.


25. Juno Pharmaceuticals

  • Website: junopharm.com
  • Ownership type: Private
  • Headquarters: Toronto, Ontario, Canada
  • Employee distribution: Canada 59%, Australia 41%
  • Founded year: 2012
  • Headcount: 51-200
  • LinkedIn: juno-pharmaceuticals

Juno Pharmaceuticals, founded in 2012 and based in Toronto, Ontario, is a private pharmaceutical company that specializes in niche and differentiated products. With a workforce of around 51-200 employees, Juno focuses on providing injectable generic drugs, branded medicines, and biosimilars to hospitals and healthcare specialists. The company operates through a model that emphasizes partnerships and innovative solutions to meet the needs of the healthcare sector. Juno's product portfolio includes a range of biosimilars, which are complex, large molecules that are challenging to develop and launch. Their commitment to addressing unmet medical needs is evident in their strategic focus on in-licensing, registration, and commercialization of these products. Juno has a significant presence in both Canada and Australia, with a strong emphasis on hospital injectable medicines, making them a notable player in the biosimilars distribution market.


26. Bioethic Pharma


Bioethic Pharma S.A., founded in 2009, is a private pharmaceutical company located in Paraguay. The company is dedicated to the development and distribution of innovative medications, biosimilars, and advanced generics. With a workforce of approximately 32 employees, Bioethic Pharma serves healthcare professionals and institutions, providing essential products across various therapeutic areas. Their commitment to quality is evident in their logistics capabilities, which include strict control measures for products requiring cold chain management. Bioethic Pharma also emphasizes the importance of pharmacovigilance, ensuring the safety and efficacy of their products post-launch. The company collaborates with renowned global laboratories, enhancing its ability to deliver high-quality biosimilars and other pharmaceutical products to a demanding market.



Biosimilars Distribution Insights: Key Companies


CompanyHeadquarterSizeFoundedOwnership
Sandoz CanadaBoucherville, Quebec, Canada201-5001980Corporate
Pharmalink Drug StoreAbu Dhabi, Abu Dhabi, United Arab Emirates (UAE)501-10001994Private
Samsung BioepisYeonsu-Gu, Incheon, South Korea501-10002012Corporate
Les Laboratoires FRATER-RAZESAlgiers [El Djazaïr], Algiers, Algeria1001-50001992Private
Kern PharmaTerrassa, Catalonia, Spain501-10001999Private
Polpharma BiologicsBrodnica Dolna, Pomeranian Voivodeship, Poland1001-50001935Private
AdalvoSan Ġwann, Malta201-5002020Private Equity
iQone Healthcare SwitzerlandVersoix, Geneva, Switzerland11-502014Corporate
Accord Healthcare BrazilSao Paulo, Sao Paulo, Brazil51-2001990Private
Usv Private LimitedMumbai, Maharashtra, India5001-100001961Private
Qilu Pharma SpainMadrid, Madrid, Spain10001+1958Private
CordavisDublin, Dublin, Ireland11-502023Private
Spirig HealthCare AGEgerkingen, Solothurn, Switzerland51-2002011Family Owned
Shilpa Biologicals Private LimitedDharwad, Karnataka, India201-5002007Private
Prime PharmaceuticalsMumbai, Maharashtra, India201-5001968Private
AryoGen PharmedIran501-10002009Private
BiogaranColombes, Île-De-France, France201-5001996Private
ApobiologixToronto, Ontario, Canada51-2002007Private
Hetero MéxicoMexico City, Mexico City, Mexico51-2002011Private
EG Italia Gruppo STADAMilan, Lombardy, Italy201-5001998Private
JHL BiotechZhubei, Hsinchu, Taiwan51-2002012Corporate
ApoPharma Inc.Toronto, Ontario, Canada51-2002004Private
JAMP Pharma GroupMontreal, Quebec, Canada201-5001988Private
EG LABO - Groupe STADAIssy-Les-Moulineaux, Île-De-France, France51-2001996Private
Juno PharmaceuticalsToronto, Ontario, Canada51-2002012Private
Bioethic PharmaParaguay51-2002009Private


Want to Find More Biosimilars Distribution Companies?

If you want to find more companies that offer biosimilars, generics, and specialized healthcare products you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.

With Inven you'll also get to know the company's:

  • Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
  • Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
  • Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!